Related references
Note: Only part of the references are listed.No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial
Lars Rolighed et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial
T. Sikjaer et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Muscle Function Is Impaired in Patients With Asymptomatic Primary Hyperparathyroidism
Lars Rolighed et al.
WORLD JOURNAL OF SURGERY (2014)
Quality of Life, Muscle Strength, and Fatigue Perception in Patients on Suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma
Dhianah Santini de Oliveira Chachamovitz et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
The Effect of PTH(1-84) on Quality of Life in Hypoparathyroidism
Natalie E. Cusano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Effect of Adding PTH(1-84) to Conventional Treatment of Hypoparathyroidism: A Randomized, Placebo-Controlled Study
Tanja Sikjaer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Reduced muscle strenght in patients with long standing hypoparathyroidism compared to healthy controls
T. Sikjaer et al.
BONE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study
Birte Nygaard et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Genetic and environmental effects on isometric muscle strength and leg extensor power followed up for three years among older female twins
Kristina Tiainen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Validation of the WHO-5 well-being index in adolescents with type 1 diabetes
Maartie de Wit et al.
DIABETES CARE (2007)
Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism
Sjur Reppe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects
Mary H. Samuels et al.
THYROID (2007)
Postural balance in a random sample of 7,979 subjects aged 30 years and over
P. Era et al.
GERONTOLOGY (2006)
Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism
EM Wekking et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism - Case report
DB Nora et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2004)
Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study
P Saravanan et al.
CLINICAL ENDOCRINOLOGY (2002)
Age- and gender-related test performance in community-dwelling elderly people:: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds
TM Steffen et al.
PHYSICAL THERAPY (2002)
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D
W Arlt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Hypoparathyroidism presenting as myopathy with raised creatine kinase
J Barber et al.
RHEUMATOLOGY (2001)
Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors
SRJ Hoare et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Share Paper
